Protections for clinical trials in low and middle income countries need strengthening not weakening.
Level V
Where this comes from
- Record sourced from PubMed, PMID 24996885.
- Also identified by DOI 10.1136/bmj.g4254 and PMC identifier 4688422.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The latest revision of the Declaration of Helsinki weakens protections for trial participants in low and middle income countries. <b>Rafael Dal-Ré and colleagues</b> argue that this is a step in the wrong direction
Medical subject headings
- Clinical Trials as Topic
- Developing Countries
- Patient Advocacy